RCKT - Rocket Pharmaceuticals GAAP EPS of -$0.82 in-line August, 10 2023 11:03 AM Rocket Pharmaceuticals Inc. 2023-08-10 11:03:25 ET Rocket Pharmaceuticals press release ( NASDAQ: RCKT ): Q2 GAAP EPS of -$0.82 in-line. Cash, cash equivalents and investments as of June 30, 2023, were $307.0 million. For further details see: Rocket Pharmaceuticals GAAP EPS of -$0.82 in-line